Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.360
-0.290-1.85%
Volume:1.09M
Turnover:16.81M
Market Cap:5.20B
PE:115.44
High:15.590
Open:15.390
Low:15.260
Close:15.650
52wk High:18.320
52wk Low:8.260
Shares:338.72M
Float Shares:275.41M
Volume Ratio:0.85
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.133
EPS(LYR):-0.029
ROE:7.36%
ROA:2.71%
PB:7.65
PE(LYR):-521.85

Loading ...

Press Release: Telix Appoints David Gill as Chair

Dow Jones
·
1 hour ago

Telix Pharmaceuticals Limited-Telix Appoints David Gill as Chair

THOMSON REUTERS
·
1 hour ago

Cochlear Stock And Two ASX Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 30

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Aug 28

Cash Flow Stocks Retail Investors May Be Missing In Australia

Simply Wall St.
·
Aug 27

Grand Pharma H1 FY26 Profit Attributable to Owners Falls 11.01% to Hk$1.06 Billion; Revenue Rises 3.2% to Hk$6.39 Billion

Reuters
·
Aug 26

Telix Pharmaceuticals Stock Leads 3 ASX Picks Trading Below Cash Flow Value

Simply Wall St.
·
Aug 25

3 Fast Growing Australian Stocks With High Insider Ownership Worth Watching

Simply Wall St.
·
Aug 25

ASX August 2026 Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.
·
Aug 25

WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value

Simply Wall St.
·
Aug 24

ASX Value Picks ALS And Two More Stocks Estimated Below Intrinsic Value

Simply Wall St.
·
Aug 24

Mesoblast Stock Leads 3 Fast Growing ASX Picks With Strong Insider Ownership

Simply Wall St.
·
Aug 23

Cash Flow Stocks Worth A Closer Look As Bond Yields Stay High

Simply Wall St.
·
Aug 23

3 Founder Led Growth Stocks With High Insider Ownership On The ASX

Simply Wall St.
·
Aug 22

Mesoblast Stock Leads 3 High Growth Insider Owned ASX Shares To Watch

Simply Wall St.
·
Aug 21

Telix Pharmaceuticals Says FY26 Revenue and Other Income Expected to be in Excess of $1 Billion

Reuters
·
Aug 20

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

THOMSON REUTERS
·
Aug 20

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Reuters
·
Aug 20

Telix Pharmaceuticals - Hy Group Revenue of Us$477 Mln

THOMSON REUTERS
·
Aug 20

Telix Pharmaceuticals - Continues to Make Good Progress Toward Near-Term Resubmission of U.S. Biologics License Application for Tlx250-Px, Zircaix

THOMSON REUTERS
·
Aug 20